| [1] | 
																						 
											Schmidt E, Kasperkiewicz M, Joly P. Pemphigus[J]. Lancet, 2019,394(10201):882⁃894. doi: 10.1016/S0140⁃6736(19)31778⁃7.
																						 | 
										
																													
																							|  [2] | 
																						 
											Rolader R, Daugherty LN, Liu Y, et al. Prevalence and predictors of pruritus in pemphigus compared with bullous pemphigoid: a cross⁃sectional study[J]. J Am Acad Dermatol, 2020,83(1):251⁃254. doi: 10.1016/j.jaad.2020.01.025.
																						 | 
										
																													
																							|  [3] | 
																						 
											赵辨. 临床皮肤病学[M]. 3版. 南京: 江苏科学技术出版社, 2001.
																						 | 
										
																													
																							|  [4] | 
																						 
											张建中, 高兴华. 皮肤性病学[M]. 北京: 人民卫生出版社, 2015.
																						 | 
										
																													
																							|  [5] | 
																						 
											Yamagami J. B⁃cell targeted therapy of pemphigus[J]. J Dermatol, 2023,50(2):124⁃131. doi: 10.1111/1346⁃8138.16653.
																						 | 
										
																													
																							|  [6] | 
																						 
											Ito M, Hoashi T, Endo Y, et al. Atypical pemphigus developed in a patient with urothelial carcinoma treated with nivolumab[J]. J Dermatol, 2019,46(3):e90⁃e92. doi: 10.1111/1346⁃8138.14601.
																						 | 
										
																													
																							|  [7] | 
																						 
											Zou H, Daveluy S. Pemphigus vulgaris after COVID⁃19 infection and vaccination[J]. J Am Acad Dermatol, 2022,87(3):709⁃710. doi: 10.1016/j.jaad.2022.05.013.
																						 | 
										
																													
																							|  [8] | 
																						 
											中国医疗保健国际交流促进会皮肤科分会. 寻常型天疱疮诊断和治疗专家建议(2020)[J]. 中华皮肤科杂志, 2020,53(1):1⁃7. doi: 10.35541/cjd.20190703.
																						 | 
										
																													
																							|  [9] | 
																						 
											Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus[J]. Nat Rev Dis Primers, 2017,3:17026. doi: 10.1038/nrdp. 2017.26.
																						 | 
										
																													
																							| [10] | 
																						 
											Akhyani M, Keshtkar⁃Jafari A, Chams⁃Davatchi C, et al. Ocular involvement in pemphigus vulgaris[J]. J Dermatol, 2014,41(7):618⁃621. doi: 10.1111/1346⁃8138.12447.
																						 | 
										
																													
																							| [11] | 
																						 
											Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care[J]. Am J Psychiatry, 2012,169(5):491⁃497. doi: 10.1176/appi.ajp.2011.11071009.
																						 | 
										
																													
																							| [12] | 
																						 
											Domínguez⁃Franco A, Méndez⁃Flores S, Ramírez⁃Marín HA, et al. Pain management in patients with severe pemphigus vulgaris[J]. J Pain Palliat Care Pharmacother, 2021,35(4):278⁃282. doi: 10.1080/15360288.2021.1963906.
																						 | 
										
																													
																							| [13] | 
																						 
											Zhao W, Wang J, Zhu H, et al. Comparison of guidelines for management of pemphigus: a review of systemic corticosteroids, rituximab, and other immunosuppressive therapies[J]. Clin Rev Allergy Immunol, 2021,61(3):351⁃362. doi: 10.1007/s12016⁃021⁃08882⁃1.
																						 | 
										
																													
																							| [14] | 
																						 
											Hamadah I, Chisti MA, Haider M, et al. Rituximab/IVIG in pemphigus ⁃ a 10⁃year study with a long follow⁃up[J]. J Dermatolog Treat, 2019,30(2):170⁃175. doi: 10.1080/09546634. 2018.1484873.
																						 | 
										
																													
																							| [15] | 
																						 
											Werth VP, Joly P, Mimouni D, et al. Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris[J]. N Engl J Med, 2021,384(24):2295⁃2305. doi: 10.1056/NEJMoa 2028564.
																						 | 
										
																													
																							| [16] | 
																						 
											Shui LP, Zhu Y, Duan XQ, et al. HBsAg (⁃)/HBsAb (⁃)/HBeAg (⁃)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B⁃cell lymphoma receiving rituximab based immunochemotherapy[J]. J Med Virol, 2023,95(2):e28549. doi: 10.1002/jmv.28549.
																						 | 
										
																													
																							| [17] | 
																						 
											Daneshpazhooh M, Balighi K, Mahmoudi H, et al. Iranian guideline for rituximab therapy in pemphigus patients[J]. Dermatol Ther, 2019,32(5):e13016. doi: 10.1111/dth.13016.
																						 | 
										
																													
																							| [18] | 
																						 
											Kridin K, Ahmed AR. Post⁃rituximab immunoglobulin M (IgM) hypogammaglobulinemia[J]. Autoimmun Rev, 2020,19(3):102466. doi: 10.1016/j.autrev.2020.102466.
																						 | 
										
																													
																							| [19] | 
																						 
											Zhang J, Huang X, Zhang Z, et al. Clinical observation of different doses of rituximab for the treatment of severe pemphigus: a single⁃center prospective cohort study[J]. J Am Acad Dermatol, 2023,88(2):500⁃502. doi: 10.1016/j.jaad.2022. 06.1187.
																						 | 
										
																													
																							| [20] | 
																						 
											Wei KC, Wang YH, Wang WH, et al. Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab[J]. J Eur Acad Dermatol Venereol, 2017,31(8):e350⁃e351. doi: 10.1111/jdv.14144.
																						 | 
										
																													
																							| [21] | 
																						 
											Pedroni MN, Hirotsu C, Porro AM, et al. The role of sleep in pemphigus: a review of mechanisms and perspectives[J]. Arch Dermatol Res, 2017,309(8):659⁃664. doi: 10.1007/s00403⁃017⁃1765⁃9.
																						 | 
										
																													
																							| [22] | 
																						 
											Brenner S. Pemphigus and diet. Have we solved the mystery of fogo selvagem?[J]. Adv Exp Med Biol, 1999,455:267⁃269.
																						 | 
										
																													
																							| [23] | 
																						 
											Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus patients[J]. Dermatology, 2001,203(3):201⁃207. doi: 10.1159/000051749.
																						 | 
										
																													
																							| [24] | 
																						 
											Kneiber D, Kowalski EH, Kridin K, et al. Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation[J]. J Eur Acad Dermatol Venereol, 2019,33(10):1935⁃1940. doi: 10.1111/ jdv.15731.
																						 | 
										
																													
																							| [25] | 
																						 
											El⁃Komy MH, Samir N, Shaker OG. Estimation of vitamin D levels in patients with pemphigus vulgaris[J]. J Eur Acad Dermatol Venereol, 2014,28(7):859⁃863. doi: 10.1111/jdv.12179.
																						 |